Anti-Antithrombin (AT) Monoclonal Antibody
AT3; ATIII; SERPINC1; Anti-Thrombin Antibodies; Serpin Peptidase Inhibitor Clade C Member 1; Coding Sequence Signal Peptide Antithrombin Part 1
- UOM
- FOB US$ 123.00 US$ 205.00 US$ 328.00 US$ 410.00 US$ 718.00
- Quantity
Overview
Properties
- Product No.FAC313Hu08
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- ApplicationsFCM
Research use only - Downloadn/a
- CategoryEnzyme & KinaseMetabolic pathwayHematology
- Ig Isotype IgG1 Kappa, Clone Number H7
- PurificationProtein A + Protein G affinity chromatography
- LabelNone
- Excitation Laser
- Vol. per test
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- TraitsLiquid
Share your citation
Upload your experimental result
Review
Leave a message
Loading...
Sign into your account
Share a new citation as an author
Upload your experimental result
Review
Please attach serial No. on instruction manual

Contact us
Please fill in the blank.
Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code*
Usage
Flow cytometry: 10µg/ml;
Optimal working dilutions must be determined by end user.
Storage
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Giveaways
Increment services
-
Protein A/G Purification Column
-
Positive Control for Antibody
-
Tissue/Sections Customized Service
-
Phosphorylated Antibody Customized Service
-
Flow Cytometry (FCM) Experiment Service
-
Immunoprecipitation (IP) Experiment Service
-
Immunofluorescence (IF) Experiment Service
-
Buffer
-
DAB Chromogen Kit
-
SABC Kit
-
Isotype Control
-
Real Time PCR Experimental Service
Citations
- Thalidomide and multiple myeloma serum synergistically induce a hemostatic imbalance in endothelial cells in vitroPubMed: 25840743
- iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Managementpubmed:29247448
- Detection of Angiotensin II and AT1 Receptor Concentrations in Keloid and Hypertrophic Scar.
- An Agile Approach to Novel Recombinant Antithrombin Production for use in Biologics Development